224 related articles for article (PubMed ID: 33879058)
1. Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study.
Suwa K; Akita K; Iguchi K; Ushio T; Maekawa Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):198. PubMed ID: 33879058
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
[TBL] [Abstract][Full Text] [Related]
3. Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.
van Dockum WG; Knaapen P; Hofman MB; Kuijer JP; ten Cate FJ; ten Berg JM; Beek AM; Twisk JW; van Rossum AC
Int J Cardiovasc Imaging; 2009 Jun; 25(5):511-8. PubMed ID: 19234870
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced Steady-state Free Precession in the Assessment of Hypertrophic Obstructive Cardiomyopathy after Alcohol Septal Ablation.
Amano Y; Yamada F; Kitamura M; Tachi M; Mine K; Kumita S; Takayama M
Magn Reson Med Sci; 2016; 15(1):130-6. PubMed ID: 26346399
[TBL] [Abstract][Full Text] [Related]
5. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
[TBL] [Abstract][Full Text] [Related]
6. Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy.
Chen YZ; Duan FJ; Yuan JS; Hu FH; Cui JG; Yang WX; Zhang Y; Wang H; Qiao SB
Heart Vessels; 2016 May; 31(5):744-51. PubMed ID: 25739657
[TBL] [Abstract][Full Text] [Related]
7. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
[TBL] [Abstract][Full Text] [Related]
8. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
[TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
10. Alcohol septal ablation markedly reduces energy loss in hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: A four-dimensional flow cardiac magnetic resonance study.
Dai Z; Iguchi N; Takamisawa I; Takayama M; Nanasato M; Kanisawa M; Mizuno N; Miyazaki S; Isobe M
Int J Cardiol Heart Vasc; 2021 Dec; 37():100886. PubMed ID: 34692989
[TBL] [Abstract][Full Text] [Related]
11. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
[TBL] [Abstract][Full Text] [Related]
12. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging.
Chen J; Nagaraj H; Bhambhani P; Kliner DE; Soman P; Garcia EV; Heo J; Iskandrian AE
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1375-84. PubMed ID: 21863321
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
Allen BD; Choudhury L; Barker AJ; van Ooij P; Collins JD; Bonow RO; Carr JC; Markl M
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):29-36. PubMed ID: 25108915
[TBL] [Abstract][Full Text] [Related]
14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy, the first cases series in Thailand.
Chamnarnphol N; Wisaratapong T
J Med Assoc Thai; 2008 Dec; 91(12):1801-5. PubMed ID: 19133512
[TBL] [Abstract][Full Text] [Related]
15. Four-dimensional Flow Cardiac MRI for Hemodynamic Assessment of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Multiple Obstructions.
Suwa K; Sato R; Iguchi K; Maekawa Y
Radiol Cardiothorac Imaging; 2023 Oct; 5(5):e230074. PubMed ID: 38076596
[TBL] [Abstract][Full Text] [Related]
16. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
[TBL] [Abstract][Full Text] [Related]
18. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
19. Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum.
Veselka J; Tomasov P; Zemánek D
J Invasive Cardiol; 2012 Dec; 24(12):636-40. PubMed ID: 23220977
[TBL] [Abstract][Full Text] [Related]
20. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
